Specialized [18F]CFA PET radiotracer showing persistent dCK activity following KRASi treatment in a mouse implanted with a tumor (left) then treated with TRE-515 to completely block dCK tumor activity (right).
Specialized [18F]CFA PET radiotracer showing persistent dCK activity following KRASi treatment in a mouse implanted with a tumor (left) then treated with TRE-515 to completely block dCK tumor activity (right).